Atlas Trials

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia

Clinical trial NCT01455025 · TERMINATED

Trial details

NCT number
NCT01455025
Sponsor
French Innovative Leukemia Organisation
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2012-01-01
Primary completion
2015-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.